Structure of microcin B-like compounds produced by pseudomonas syringae and species specificity of their antibacterial action

Journal of Bacteriology

Volumn 195, Issue 18, 2013, Pages 4129-4137

  Metelev, Mikhail ^a   Serebryakov, Marina ^a,b   Ghilarov, Dmitry ^a   Zhao, Youfu ^c   Severinov, Konstantin ^a,d,e  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d PETER THE GREAT ST PETERSBURG POLYTECHNIC UNIVERSITY   (Russian Federation)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); MICROCIN B; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GROWTH INHIBITION; HETEROLOGOUS EXPRESSION; MOLECULAR CLONING; NONHUMAN; OPERON; PLANT DISEASE; PRIORITY JOURNAL; PSEUDOMONAS SYRINGAE; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; CLONING, MOLECULAR; DNA GYRASE; ESCHERICHIA COLI; HUMANS; OPERON; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS SYRINGAE; SPECIES SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84883261261     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00665-13     Document Type: Article

References (32)

1. Asensio C, Perez-Diaz JC, Martinez MC, Baquero F. 1976. A new family of low molecular weight antibiotics from enterobacteria. Biol. Biophys. Res. Commun. 69:7-14.
2. Severinov K, Semenova E, Kazakov A, Kazakov T, Gelfand MS. 2007. Low-molecular-weight post-translationally modified microcins. Mol. Microbiol. 65:1380-1394.
3. Duquesne S, Petit V, Peduzzi J, Rebuffat S. 2007. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria. J. Mol. Microbiol. Biotechnol. 13:200-209.
4. Lee SW, Mitchell DA, Markley AL, Hensler ME, Gonzalez D, Wohlrab A, Dorrestein PC, Nizet V, Dixon JE. 2008. Discovery of a widely distributed toxin biosynthetic gene cluster. Proc. Natl. Acad. Sci. U. S. A. 105:5879-5884.
5. Watrous J, Roach P, Alexandrov T, Heath BS, Yang JY, Kersten RD, van der Voort M, Pogliano K, Gross H, Raaijmakers JM, Moore BS, Laskin J, Bandeira N, Dorrestein PC. 2012. Mass spectral molecular networking of living microbial colonies. Proc. Natl. Acad. Sci. U. S. A. 109:1743-1752.
6. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, et al. 2013. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 30:108-160.
7. Yorgey P, Lee J, Kördel J, Vivas E, Warner P, Jebaratnam D, Kolter R. 1994. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 91:4519-4523.
8. Li YM, Milne JC, Madison LL, Kolter R, Walsh CT. 1996. From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase. Science 274:1188-1193.
9. Milne JC, Roy RS, Eliot AC, Kelleher NL, Wokhlu A, Nickels B, Walsh CT. 1999. Cofactor requirements and reconstitution of microcin B17 synthetase: a multienzyme complex that catalyzes the formation of oxazoles and thiazoles in the antibiotic microcin B17. Biochemistry 38:4768-4781.
10. Garrido MC, Herrero M, Kolter R, Moreno F. 1988. The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J. 7:1853-1862.
11. Sinha Roy R, Kelleher NL, Milne JC, Walsh CT. 1999. In vivo processing and antibiotic activity of microcin B17 analogs with varying ring content and altered bisheterocyclic sites. Chem. Biol. 6:305-318.
12. Ghilarov D, Serebryakova M, Shkundina I, Severinov K. 2011. A major portion of DNA gyrase inhibitor microcin B17 undergoes an N,Opeptidyl shift during synthesis. J. Biol. Chem. 286:26308-26318.
13. Allali N, Afif H, Couturier M, Van Melderen L. 2002. The highly conserved TldD and TldE proteins of Escherichia coli are involved in microcin B17 processing and in CcdA degradation. J. Bacteriol. 184:3224-3231.
14. Mitchell DA, Lee SW, Pence MA, Markley AL, Limm JD, Nizet V, Dixon JE. 2009. Structural and functional dissection of the heterocyclic peptide cytotoxin streptolysin S. J. Biol. Chem. 284:13004-13012.
15. Qi M, Wang D, Bradley CA, Zhao Y. 2011. Genome sequence analyses of Pseudomonas savastanoi pv. glycinea and subtractive hybridization-based comparative genomics with nine pseudomonads. PLoS One 6:e16451.
16. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
17. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
18. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
19. Joardar V, Lindeberg M, Jackson RW, Selengut J, Dodson R, Brinkac LM, Daugherty SC, Deboy R, Durkin AS, Giglio MG, Madupu R, Nelson WC, Rosovitz MJ, Sullivan S, Crabtree J, Creasy T, Davidsen T, Haft DH, Zafar N, Zhou L, Halpin R, Holley T, Khouri H, Feldblyum T, White O, Fraser CM, Chatterjee AK, Cartinhour S, Schneider DJ, Mansfield J, Collmer A, Buell CR. 2005. Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola 1448A reveals divergence among pathovars in genes involved in virulence and transposition. J. Bacteriol. 187:6488-6498.
20. Feil H, Feil WS, Chain P, Larimer F, DiBartolo G, Copeland A, Lykidis A, Trong S, Nolan M, Goltsman E, Thiel J, Malfatti S, Loper JE, Lapidus A, Detter JC, Land M, Richardson PM, Kyrpides NC, Ivanova N, Lindow SE. 2005. Comparison of the complete genome sequences of Pseudomonas syringae pv. syringae B728a and pv. tomato DC3000. Proc. Natl. Acad. Sci. U. S. A. 102:11064-11069.
21. Buell CR, Joardar V, Lindeberg M, Selengut J, Paulsen IT, Gwinn ML, Dodson RJ, Deboy RT, Durkin AS, Kolonay JF, Madupu R, Daugherty S, Brinkac L, Beanan MJ, Haft DH, Nelson WC, Davidsen T, Zafar N, Zhou L, Liu J, Yuan Q, Khouri H, Fedorova N, Tran B, Russell D, Berry K, Utterback T, Van Aken SE, Feldblyum TV, D'Ascenzo M, Deng WL, Ramos AR, Alfano JR, Cartinhour S, Chatterjee AK, Delaney TP, Lazarowitz SG, Martin GB, Schneider DJ, Tang X, Bender CL, White O, Fraser CM, Collmer A. 2003. The complete genome sequence of the Arabidopsis and tomato pathogen Pseudomonas syringae pv. tomato DC3000. Proc. Natl. Acad. Sci. U. S. A. 100:10181-10186.
22. Genilloud O, Moreno F, Kolter R. 1989. DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J. Bacteriol. 171:1126-1135.
23. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
24. Reece RJ, Maxwell A. 1991. Probing the limits of the DNA breakagereunion domain of the Escherichia coli DNA gyrase A protein. J. Biol. Chem. 266:3540-3546.
25. Heddle JG, Blance SJ, Zamble DB, Hollfelder F, Miller DA, Wentzell LM, Walsh CT, Maxwell A. 2001. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. J. Mol. Biol. 307:1223-1234.
26. Laviña M, Pugsley AP, Moreno F. 1986. Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. J. Gen. Microbiol. 132:1685-1693.
27. Han MJ, Lee SY, Hong SH. 2012. Comparative analysis of envelope proteomes in Escherichia coli B and K-12 strains. J. Microbiol. Biotechnol. 22:470-478.
28. Vizán JL, Hernández-Chico C, del Castillo I, Moreno F. 1991. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J. 10:467-476.
29. Sinha Roy R, Belshaw PJ, Walsh CT. 1998. Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase inhibitor microcin B17: distance dependence from propeptide and tolerance for substitution in a GSCG cyclizable sequence. Biochemistry 37:4125-4136.
30. Collin F, Thompson RE, Jolliffe KA, Payne RJ, Maxwell A. 2013. Fragments of the bacterial toxin microcin b17 as gyrase poisons. PLoS One 8:e61459.
31. Moreno F, Gónzalez-Pastor JE, Baquero MR, Bravo D. 2002. The regulation of microcin B, C and J. operons. Biochimie 84:521-529.
32. Belshaw PJ, Roy RS, Kelleher NL, Walsh CT. 1998. Kinetics and regioselectivity of peptide-to-heterocycle conversions by microcin B17 synthetase. Chem. Biol. 5:373-384.